⌘K

Login Start Free

Home/Filings/4/0001415889-24-025460

4//SEC Filing

Scigalla Paul 4

Accession 0001415889-24-025460

CIK 0001231457other

View on SEC.gov Company Profile

Filed

Oct 20, 8:00 PM ET

Accepted

Oct 21, 5:05 PM ET

Size

7.6 KB

Accession

0001415889-24-025460

Insider Transaction Report

Form 4

Period: 2024-10-18

GENELUX CorpGNLX

Chief Medical Officer

Transactions

Award
Stock Option (right to buy)
2024-10-18+16,666→ 16,666 total
Exercise: $6.00Exp: 2034-10-17→ Common Stock (16,666 underlying)
Award
Stock Option (right to buy)
2024-10-18+16,666→ 16,666 total
Exercise: $6.00Exp: 2034-10-17→ Common Stock (16,666 underlying)

Footnotes (2)

[F1]Immediately exercisable.
[F2]100% of the shares subject to the Option shall vest on December 31, 2024.

Documents

1 file

4
form4-10212024_051002.xmlPrimary

Issuer

GENELUX Corp

CIK 0001231457

Entity typeother

Related Parties

1

filerCIK 0001937586

Filing Metadata

Form type: 4
Filed: Oct 20, 8:00 PM ET
Accepted: Oct 21, 5:05 PM ET
Size: 7.6 KB

View on SEC.gov